Evidence map›Paper›PMID 32961731›Full record

ArticleMolecules (Basel, Switzerland)2020

UCNP-based Photoluminescent Nanomedicines for Targeted Imaging and Theranostics of Cancer.

Evgenii L Guryev, Anita S Smyshlyaeva, Natalia Y Shilyagina, Evgeniya A Sokolova, Samah Shanwar, Alexey B Kostyuk, Alexander V Lyubeshkin, Alexey A Schulga, Elena V Konovalova, Quan Lin and 4 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Bioimaging with Upconversion Nanoparticles.Advanced photonics research · 2022
    Article
  7. Photon Upconversion in Small Molecules.Molecules (Basel, Switzerland) · 2022
    Review
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Evgenii L GuryevInstitute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.ORCID 0000-0002-8845-436X
Anita S SmyshlyaevaInstitute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.
Natalia Y ShilyaginaInstitute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.
Evgeniya A SokolovaInstitute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.
Samah ShanwarInstitute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.
Alexey B KostyukInstitute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.
Alexander V LyubeshkinFederal Scientific Research Center "Crystallography and Photonics", Russian Academy of Sciences, 119333 Moscow, Russia.ORCID 0000-0003-1086-7700
Alexey A SchulgaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.ORCID 0000-0003-3425-0828
Elena V KonovalovaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
Quan LinCollege of Chemistry, Jilin University, Changchun 130012, China.
Indrajit RoyDepartment of Chemistry, University of Delhi, Delhi 110007, India.
Irina V BalalaevaInstitute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.ORCID 0000-0002-3245-3907
Sergey M DeyevShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
Andrei V ZvyaginInstitute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.ORCID 0000-0001-8799-2257
N. I. Lobachevsky State University of Nizhny Novgorod · RUInstitute of Bioorganic Chemistry · RUSechenov University · RUJilin University · CNRussian Academy of Sciences · RUUniversity of Delhi · IN

Funding

Ministry of Science and Higher Education of the Russian Federation RFMEFI58418X0033
6 · The paper itself

Abstract

Theranostic approach is currently among the fastest growing trends in cancer treatment. It implies the creation of multifunctional agents for simultaneous precise diagnosis and targeted impact on tumor cells. A new type of theranostic complexes was created based on NaYF

Indexed as

Theranostic NanomedicineAnimalsBreast NeoplasmsCell Line, TumorCell SurvivalErb-b2 Receptor Tyrosine KinasesFemaleFluorescent DyesFluoridesHumansMetal NanoparticlesMiceMice, NudePolyethylene GlycolsThuliumTransplantation, HeterologousERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesFluorescent DyesFluoridesPolyethylene Glycolssodium yttriumtetrafluorideThuliumYtterbiumYttriumantigendrugimagingimmunoconjugatestherapytumor

Identifiers

PMID32961731
PMCPMC7571190
OpenAlexW3087013173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.